EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 10-Jul-2025 04:10 ET (10-Jul-2025 08:10 GMT/UTC)

Moffitt study finds key biomarker to predict KRASG12C inhibitor effectiveness in lung cancer

H. Lee Moffitt Cancer Center & Research Institute
Peer-Reviewed Publication

A new study from Moffitt Cancer Center could help doctors predict how well patients with a specific type of lung cancer will respond to new therapies. The research, published in Clinical Cancer Research, found that measuring the interaction between two proteins, RAS and RAF, could provide valuable insights into the effectiveness of treatments for patients with KRASG12C-mutant non-small cell lung cancer, a type of lung cancer known for being particularly difficult to treat.

Journal: Clinical Cancer Research
Funder: NIH/National Cancer Institute, NIH/National Cancer Institute, Revolution Medicines, H. Lee Moffitt Cancer Center and Research Institute

UCLA-led study establishes link between early side effects from prostate cancer radiation and long-term side effects

University of California - Los Angeles Health Sciences
Peer-Reviewed Publication

Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of developing more serious long-term urinary and bowel health issues, according to a new study led by investigators from the UCLA Health Jonsson Comprehensive Cancer Center.

Journal: The Lancet Oncology
Funder: NIH/National Institutes of Health, U.S. Department of Defense

City of Hope scientists identify mechanism for self-repair of the thymus, a crucial component of the immune system

City of Hope
Peer-Reviewed Publication

City of Hope scientists identify a mechanism for self-repair of the thymus, a crucial component of the immune system, with research published in Immunity that could help boost thymic function after damage from cancer therapies and other factors

Journal: Immunity

How UIC scientists redesigned an effective cancer therapy to make it safer

University of Illinois Chicago
Reports and Proceedings

University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage. If approved, the new drug may be tolerated by a broader range of leukemia patients and even be used to treat other cancers.

Anti-melanoma activity found in green-produced nanosilver-chlorhexidine complex

Pensoft Publishers
Peer-Reviewed Publication

A complex between green-synthesized silver nanoparticles and chlorhexidine has shown explicit anti-tumor activity against human melanoma. A trustful concentration range was established in which the active agent was effective against the cancer cells but remained non-toxic to the normal cells. The findings were published in the open-access journal Pharmacia.

Journal: Pharmacia

Low-level traffic air pollution linked to liver damage and fatty liver disease

University of Technology Sydney
Peer-Reviewed Publication

Low levels of traffic-related air pollution harms the liver and may raise the risk of metabolic-associated fatty liver disease, a new study in mice suggests.

Journal: Journal of Environmental Sciences
Funder: Australian National Health & Medical Research Council

UT Health San Antonio School of Dentistry researcher and her company earn Small Business Technology Transfer grant

University of Texas Health Science Center at San Antonio
Grant and Award Announcement

A researcher with The University of Texas Health Science Center at San Antonio School of Dentistry and her biotechnology company teamed with the school to earn a $400,000 Small Business Technology Transfer (STTR) grant, funded by the National Institutes of Health, aimed at getting a breakthrough oral cancer drug to market faster.

New MSK research a step toward off-the-shelf CAR T cell therapy for cancer

Memorial Sloan Kettering Cancer Center
Peer-Reviewed Publication

MSK researchers engineer better CAR T cells by borrowing a tool that viruses use to evade immune detection.

Journal: Nature

New robotic surgical systems revolutionizing patient care

Huntsman Cancer Institute
Business Announcement

The introduction of two da Vinci 5 systems enhances surgery precision and safety, decreasing recovery times for patients. This innovative technology strengthens Huntsman Cancer Institute’s role as a leader in robotic surgical care.

Removing fallopian tubes during other abdominal surgeries may lower ovarian cancer risk

PLOS
Peer-Reviewed Publication

A mathematical modeling study conducted in Germany suggests that ovarian cancer incidence could be reduced and healthcare savings boosted if women who have already completed their families were offered fallopian tube removal during any other suitable abdominal surgeries. Angela Kather and Ingo Runnebaum of Jena University Hospital, Germany, and colleagues present these findings on January 30^th in the open-access journal PLOS Medicine.

Journal: PLOS Medicine